Pharmaceutics 2012, 4(3), 430-441; doi:10.3390/pharmaceutics4030430
Article

Influence of the Efavirenz Micronization on Tableting and Dissolution

Eduardo Costa Pinto 1 email, Flávia Almada do Carmo 1,* email, Thiago da Silva Honório 1 email, Rita de Cássia da Silva Ascenção Barros 1 email, Helena Carla Rangel Castro 2 email, Carlos Rangel Rodrigues 1 email, Valéria Sant'Anna Dantas Esteves 1,3 email, Helvécio Vinícius Antunes Rocha 3 email, Valeria Pereira de Sousa 1 email and Lucio Mendes Cabral 1 email
2 Laboratory of Antibiotics, Biochemistry, Institute of Biology, Universidade Federal Fluminense, Campus of Valonguinho, Niterói, RJ, CEP: 24.210-130, Brazil 3 Institute of Drug Technology, Fundação Oswaldo Cruz, Av. Comandante Guaranys, 447, Curicica, Rio de Janeiro, RJ, CEP: 22.775-903, Brazil
* Author to whom correspondence should be addressed.
Received: 8 August 2012; in revised form: 2 September 2012 / Accepted: 2 September 2012 / Published: 12 September 2012
PDF Full-text Download PDF Full-Text [590 KB, uploaded 12 September 2012 16:11 CEST]
Abstract: The purpose of this study was to propose an analytical procedure that provides the effects of particle size and surface area on dissolution of efavirenz. Five different batches obtained by different micronization processes and with different particle size distribution and surface area were studied. The preformulation studies and dissolution curves were used to confirm the particle size distribution effect on drug solubility. No polymorphic variety or amorphization was observed in the tested batches and the particle size distribution was determined as directly responsible for the improvement of drug dissolution. The influence of the preparation process on the tablets derived from efavirenz was observed in the final dissolution result in which agglomeration, usually seen in non-lipophilic micronized material, was avoided through the use of an appropriate wet granulation method. For these reasons, micronization may represent one viable alternative for the formulation of brick dust drugs.
Keywords: AIDS; size distribution; surface area; bioavailability; brick dust drug

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Pinto, E.C.; Carmo, F.A.; Honório, T.S.; Barros, R.C.S.A.; Castro, H.C.R.; Rodrigues, C.R.; Esteves, V.S.D.; Rocha, H.V.A.; Sousa, V.P.; Cabral, L.M. Influence of the Efavirenz Micronization on Tableting and Dissolution. Pharmaceutics 2012, 4, 430-441.

AMA Style

Pinto EC, Carmo FA, Honório TS, Barros RCSA, Castro HCR, Rodrigues CR, Esteves VSD, Rocha HVA, Sousa VP, Cabral LM. Influence of the Efavirenz Micronization on Tableting and Dissolution. Pharmaceutics. 2012; 4(3):430-441.

Chicago/Turabian Style

Pinto, Eduardo Costa; Carmo, Flávia Almada do; Honório, Thiago da Silva; Barros, Rita de Cássia da Silva Ascenção; Castro, Helena Carla Rangel; Rodrigues, Carlos Rangel; Esteves, Valéria Sant'Anna Dantas; Rocha, Helvécio Vinícius Antunes; Sousa, Valeria Pereira de; Cabral, Lucio Mendes. 2012. "Influence of the Efavirenz Micronization on Tableting and Dissolution." Pharmaceutics 4, no. 3: 430-441.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert